The Food & Drug Administration issued its highest priority recall for counterfeit versions of C.R. Bard’s (NYSE:BCR) Davol Inc. brand. surgical mesh.
The federal watchdog agency warned that the fake versions of the product, commonly known as Marlex mesh, should not be used. Investigations by the FDA and Bard found most of the counterfeit product is labeled with genuine Bard lot numbers.
The Class I recall is an update to a March 11 warning that announced the investigation.